Is StriVectin Better Than Botox? Not Without NDA Approval, FDA Says

Klein-Becker's signature statement for StriVectin-SD anti-aging cream - "Better than Botox?" - constitutes a structure/function claim that would require the product to be regulated as a drug, the agency states in a 1warning letter recently posted on its Web site

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

Valbiotis Launches Plant-Based Heart Health Supplement

 
• By 

Available in French pharmacies and online, ValbiotisPRO Cardio-circulation comprises a blend of six plant extracts and is targeted at those with high blood pressure.

L’Oréal, NVIDIA Partner To ‘Unlock’ AI’s Potential Across Beauty

 

L’Oréal SA and NVIDIA Corp. are collaborating to unlock AI’s potential access across beauty, including innovation, scalability, and personalized marketing, the French beauty firm and the tech company announced during the Viva Technology show in Paris.

Xlear Lawsuit Argues To Shelve FTC Policy For Health Claim Substantiation Under Loper Bright

 

Complaint filed Utah federal court says “Supreme Court explicitly rejected Chevron deference to agency interpretations” in the Loper decision, compelling rejection of “an agency’s statutory interpretation unless the court, ‘after applying all relevant interpretive tools, concludes’ the interpretatio